Multikine cytokine mixture: CELI began a Phase I/II trial

Cel-Sci Corp. (CELI), Alexandria, Va.
Product: Multikine cytokine mixture
Indication: Squamous cell carcinoma

Read the full 130 word article

How to gain access

Continue reading with a
two-week free trial.